NICE urgent cancer referral guidance (guidelines with respect to primary care investigations)

Last reviewed 06/2021

This part of the database outlines NICE urgent cancer referral guidance with respect to possible investigations (and results from these) undertaken in primary care.

Reference:

Related pages:

NICE urgent cancer referral guidance

NICE urgent cancer referral guidance (guidelines with respect to presenting symptoms and signs)

anaemia - NICE urgent cancer referral guidance

blood glucose levels - NICE urgent cancer referral guidance

hypercalcaemia or leukopenia and presentation consistent with possible myeloma, 60 and over - NICE urgent cancer referral guidance

plasma viscosity (PV) or erythrocyte sedimentation rate (ESR) and presentation consistent with possible myeloma - NICE urgent cancer referral guidance

PSA (NICE urgent referral guidance for suspected cancer)

protein electrophoresis suggests myeloma - NICE urgent cancer referral guidance

Ca125 (Ca - 125) - NICE urgent cancer referral guidance

raised platelet count (thrombocytosis) - NICE urgent cancer referral guidance

raised white cell count - NICE urgent cancer referral guidance

NICE guidance - use of faecal occult blood (FOB) testing to identify possible colorectal cancer